BRYNJELSEN SEAN 4
4 · Eton Pharmaceuticals, Inc. · Filed Mar 16, 2020
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Award
Stock Option (Right to buy)
2020-03-12+490,000→ 490,000 totalExercise: $3.58Exp: 2030-03-11→ Common Stock (490,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in 24 equal monthly installments from the date of grant until fully vested and exercisable on March 12, 2022.